Analysis of trials evaluating combinations of acetylsalicylic acid and dipyridamole in the secondary prevention of stroke

Clinical Therapeutics

Volumn 23, Issue 9, 2001, Pages 1391-1408

  Redman, Andrea R ^a   Ryan, Gina J ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

Acetylsalicylic acid; Aspirin; Cerebrovascular disorders; Dipyridamole; Ischemic stroke

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; PROSTACYCLIN; THROMBOXANE A2;

CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; NAUSEA; OUTCOMES RESEARCH; PARESTHESIA; PATIENT COMPLIANCE; PEPTIC ULCER; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; SECONDARY PREVENTION; STOMACH PAIN; STROKE; THROMBOCYTE AGGREGATION INHIBITION; TRANSIENT ISCHEMIC ATTACK; VERTIGO; VOMITING;

EID: 0034801373     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80115-6     Document Type: Article

References (31)

1. Lifetime cost of stroke in the United States
2. Stroke
3. Probability of stroke: A risk profile from the Framingham Study
4. Antithrombotic and thrombolytic therapy for ischemic stroke
5. Antiplatelet therapy in cardiovascular disease
6. Aspirin, platelets, and thrombosis: Theory and practice
7. Clopidogrel: An antithrombotic drug acting on the ADP-dependent activation pathway of human platelets
8. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: A difficult link
9. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia
10. Persantine Aspirin Trial in cerebral ischemia Part II: Endpoint results
11. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
12. European Stroke Prevention Study
13. Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks
14. Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia
15. Platelet thromboxane synthetase inhibitors with low doses of aspirin: Possible resolution of the "aspirin dilemma"
16. The European Stroke Prevention Study (ESPS): Principal end points
17. Persantine Aspirin Trial in cerebral ischemia
18. Time to stop counting the tablets?
19. Pill count measures of compliance in a drug trial: Variability and suitability
20. Enhancing patients' compliance: Electronic monitoring approaches should be more widely used
21. On white-coat effects and the electronic monitoring of compliance
22. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens
23. Compliance, electronic monitoring and antihypertensive drugs
24. Hematologic disorders
25. Secondary prevention of vascular disease by prolonged antiplatelet treatment
26. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events
27. The United Kingdom Transient Ischaemic Attack (UK-TIA) aspirin trial: Final results
28. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke